Abiopharma

🔍 PIERCE FREDERICK II (Executive)

Company: Decoy Therapeutics Inc. (DCOY)

Report Date: 2026-08-31

Detailed Transactions and Holdings:

• Acquired 33,455 shares of Common Stock (Direct)
  Date: 2026-08-31 | Code: A | equity_swap_involved: false | shares_owned_after: 34,844.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Restricted stock granted under the Decoy Therapeutics Inc. 2026 Equity Incentive Plan. 25 percent of the restricted stock vested immediately, and the remainder will vest in approximately equal monthly increments over the next 36 months.
• F2: Shares beneficially owned following the transaction have been adjusted to reflect the reverse stock split effective on March 6, 2026.